Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
GSK to Acquire Nuvalent in $10.6 Billion Oncology Deal
Ropes & Gray LLP has advised Nuvalent, Inc. Davis Polk & Wardwell LLP and Slaughter and May have advised GSK plc. Sidley Austin LLP has represented...
Neomorph Raises $100 Million in Series B Financing
Sidley Austin has advised Neomorph, Inc. Neomorph, Inc., a biotechnology company focused on molecular glue degraders, has closed a $100 million Series B financing round. Deerfield...
Crossbow Therapeutics Secures US$77 Million Series B Funding to Advance Cancer Immunotherapy Program
Sidley has advised Crossbow Therapeutics on the deal. Crossbow Therapeutics, a biotechnology company specializing in the development of next-generation antibody therapies targeting a wide range of...
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
Nuvalent’s $575 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Nuvalent, Inc. in the offering, and Simpson Thacher & Bartlett represented the underwriters. Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage...
Orna Therapeutics’ Acquisition of ReNAgade Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Orna Therapeutics on the transaction. Orna Therapeutics, a biotechnology company, announced its acquisition of ReNAgade Therapeutics, a pioneer in...
MKS Instruments’ $1.4 Billion Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
Astria Therapeutics’ $125 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Astria Therapeutics, Inc., and Cooley advised the underwriters. Astria Therapeutics, Inc. (Astria) (Nasdaq: ATXS) announced it completed its underwritten registered...
Georgiamune’s $75 Million Series A Financing Round
Wilmer Cutler Pickering Hale and Dorr advised Georgiamune Inc. on the transaction. Georgiamune Inc. announced the clearance of its Investigational New Drug application by the US Food...
Eli Lilly’s $487 Million Acquisition of Akouos
Kirkland & Ellis represented Lilly, while Wilmer Cutler Pickering Hale and Dorr represented Akouos in the transaction. Eli Lilly and Company (NYSE: LLY) announced its acquisition...